Sands Capital Alternatives, LLC - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 13, 2026, for the 2025 Q4 period, Sands Capital Alternatives, LLC held in its portfolio 20 assets valued at $518,465,381 (i.e. $518.47M).

The most valuable assets in the portfolio included: KLAVIYO INC ($118.51M), NU HLDGS LTD ($114.86M), and BETA BIONICS INC ($108.78M).

The chart below shows the top 10 valuable assets, and the table below shows the top 20 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Sands Capital Alternatives, LLC Portfolio

KLAVIYO INC

NU HLDGS LTD

BETA BIONICS INC

INHIBIKASE THERAPEUTICS INC

DOORDASH INC

COUPANG INC

SAMSARA INC

DATADOG INC

TOAST INC

BIOAGE LABS INC

Sands Capital Alternatives, LLC - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
KLAVIYO INC	3649678	118505045	COM SER A
NU HLDGS LTD	6861399	114859819	ORD SHS CL A
BETA BIONICS INC	3570113	108781343	COM
INHIBIKASE THERAPEUTICS INC	13018965	26688878	COM NEW
DOORDASH INC	95618	21655565	CL A
COUPANG INC	870424	20533302	CL A
SAMSARA INC	466190	16526436	COM CL A
DATADOG INC	85793	11666990	CL A COM
TOAST INC	301647	10711485	CL A
BIOAGE LABS INC	786353	10403450	COM
MONDAY COM LTD	67868	10014602	SHS
SERVICETITAN INC	89856	9569664	SHS CL A
10X GENOMICS INC	481770	7857669	CL A COM
ACUMEN PHARMACEUTICALS INC	3417075	7210028	COM
TARSUS PHARMACEUTICALS INC	85000	6959800	COM
ACRIVON THERAPEUTICS INC	2122605	5115478	COMMON STOCK
SNOWFLAKE INC	20253	4442698	COM SHS
TAYSHA GENE THERAPIES INC	724873	3986802	COM SHS
CANDEL THERAPEUTICS INC	405837	2292979	COM
FIGMA INC	18286	683348	CLASS A COM STK